πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 1,641 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 8110192

Human immunodeficiency virus type 1 (HIV-1)-neutralizing human single-chain antibodies wit

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Feb 07 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 02 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8106027

Development of a preventive vaccine for filovirus infection in primates

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Jan 31 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 26 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8105609

Flavivirus immunogens comprising extracellular viral particles composed of the premembrane

The United States of America as represented by the Secretary of the Department of Health and Human Services, Centers for Disease Control and Prevention Β· Granted Tue Jan 31 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 26 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8106026

Development of a preventive vaccine for filovirus infection in primates

The United States of America as Represented by the Secretary of the Department of Health and Human Services Β· Granted Tue Jan 31 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 26 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8101739

Recombinant expression vectors comprising a human codon-optimized marburg virus (MARV) ang

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Jan 24 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 19 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8101172

Solenopsis invicta virus

The United States of America, as represented by the Secretary of Agriculture Β· Granted Tue Jan 24 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 19 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8088729

Anti-viral griffithsin compounds, compositions and methods of use

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Jan 03 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 29 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8084248

Reverse genetic system for rift valley fever virus and uses thereof

The Board of Regents of the University of Texas System Β· Granted Tue Dec 27 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 22 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8084594

H2N3 influenza A viruses and methods of use

The United States of America, as represented by the Secretary of Agriculture Β· Granted Tue Dec 27 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 22 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8080241

Viruses for the treatment of cellular proliferative disorders

ONCOLYTICS BIOTECH INC. Β· Granted Tue Dec 20 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 15 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8075903

Dengue tetravalent vaccine containing a common 30 nucleotide deletion in the 3β€²-UTR of den

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Dec 13 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 08 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8076372

Acythiols and component thiol compositions as anti-HIV and anti-retroviral agents

The Government of the United States Β· Granted Tue Dec 13 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 08 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8076451

Selective delivery of molecules into cells or marking of cells in diseased tissue regions

Board of Governors for Higher Education, State of Rhode Island and Providence Plantations Β· Granted Tue Dec 13 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 08 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8071087

Reovirus for the treatment of cellular proliferative disorders

ONCOLYTICS BIOTECH INC. Β· Granted Tue Dec 06 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 01 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8071107

Nucleic acids encoding modified human immunodeficiency virus type 1 (HIV-1) group M consen

The Regents of the University of California Β· Granted Tue Dec 06 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 01 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8067530

Scytovirin domain 1 related polypeptides

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Nov 29 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 24 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8066985

Reovirus for the treatment of cellular proliferative disorders

ONCOLYTICS BIOTECH INC. Β· Granted Tue Nov 29 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 24 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8063195

Mutations in a toll-like receptor motif in the NS4B of classical swine fever virus strain

The United States of America, as represented by the Secretary of Agriculture Β· Granted Tue Nov 22 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 17 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8058257

Compositions and methods for inhibiting expression of a gene from the JC virus

Alnylam Pharmaceuticals, Inc. Β· Granted Tue Nov 15 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 10 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8058248

Foot and mouth disease virus vaccine comprising interferons

The United States of America, as represented by the Secretary of Agriculture Β· Granted Tue Nov 15 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 10 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8048427

Subgenomic replicons of the flavivirus dengue

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Nov 01 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 27 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8039003

Recombinant attenuated dengue viruses comprising a deletion in the 3β€² untranslated region

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Oct 18 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 13 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8039001

Therapeutic and prophylactic vaccine for the treatment and prevention of papillomavirus in

The Regents of the University of Colorado, a Body Corporate Β· Granted Tue Oct 18 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 13 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8039008

Identification of residues critical for the function of the vibrio cholerae virulence regu

The Board of Regents of the University of Texas System Β· Granted Tue Oct 18 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 13 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted